Biotech IPO window is open, but big pharma M&As set the pace: bankers
Public markets are beginning to reopen for biotech companies after several years of subdued activity. But stronger companies are still…
Novartis AG
The reality of Trump's drug prices will be set in the next 18 months
NovartisThe CEO warned Tuesday that U.S. drug pricing policy under President Donald Trump poses a “very difficult situation” and that…
Novartis, Amgen and Eli Lilly's Lp(a) Drugs Aim to Prevent Heart Attacks
Pharma believes it has found the next frontier in heart attack prevention. Novartis, amgen and Eli Lilly are among drugmakers…
Trump administration takes steps to reclassify cannabis
The Trump administration moved Thursday to reclassify cannabis under federal law, which could significantly expand scientific research into the drug's…
Novartis and Genentech sue for illegal importation of prescription drugs
A sign for Swiss pharmaceutical giant Novartis is seen atop a building in Basel, Switzerland, on September 9, 2025. Fabrice…
White House launches direct-to-consumer drug site
President Donald Trump makes an announcement from the Oval Office of the White House in Washington, November 6, 2025. Jonathan…
15 drugs added to Medicare price negotiations
Boxes of the drug Trulicity, manufactured by Eli Lilly and Company, sit on a pharmacy counter in Provo, Utah, on…
Another Alliance Between Healthcare and AI Indicates Why Pharma Stocks Could Make a Comeback
Bristol Myers Squibb and Microsoft's new partnership aimed at accelerating the early detection of lung cancer marks the latest way…
Nine pharmaceutical companies sign agreements with Trump to lower drug prices
US President Donald Trump speaks during an event in the Roosevelt Room of the White House on December 19, 2025…
Novartis has potential for big M&A deals, CEO says
This photo taken on October 30, 2022 shows the logo of Swiss pharmaceutical company Novartis on a building in Basel.…